Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/28/2025

Diagnostic Guidelines for Muscular Dystrophy

Clinical Suspicion Triggers

  • The American Academy of Neurology and Child Neurology Society recommend suspecting muscular dystrophy in male children with abnormal muscle function, including delayed walking beyond 16-18 months, frequent falls, difficulty with running and climbing stairs, or presence of Gowers' sign, especially under 5 years old 1, 2
  • Elevated serum creatine kinase levels, typically 10-100 times the upper limit of normal, strongly suggest muscular dystrophy and should trigger immediate genetic testing in male children 1, 2
  • Unexplained elevated transaminases in any male child should prompt consideration of muscular dystrophy before proceeding to liver biopsy 1, 2

Diagnostic Algorithm

  • The European Academy of Neurology recommends measuring serum creatine kinase concentrations as the initial screening step, with markedly elevated levels confirming the need for definitive diagnostic testing 1, 2
  • Genetic testing, including dystrophin deletion/duplication testing using PCR multiplex and multiplex ligation-dependent probe amplification (MLPA), is the first-line diagnostic approach for muscular dystrophy 1, 2
  • If genetic testing is negative, muscle biopsy may be necessary to distinguish DMD from milder phenotypes or to evaluate for alternative muscular dystrophies 1, 2

Post-Diagnosis Requirements

  • The American Academy of Pediatrics recommends referral to specialized multidisciplinary neuromuscular care within days of diagnosis, as well as genetic counseling for all at-risk female family members 1, 2
  • Baseline cardiac evaluation with ECG and echocardiogram should be performed at diagnosis or by age 6 years, according to the American Heart Association 4, 3
  • Comprehensive neuropsychological assessment should be conducted at diagnosis and before school entry to establish baseline cognitive function, as recommended by the American Academy of Neurology 4

Diagnostic Pitfalls to Avoid

  • The American College of Medical Genetics and Genomics advises against performing liver biopsy in male children with elevated transaminases before ruling out muscular dystrophy with CK testing 1, 2, 3
  • Genetic testing should not be delayed while waiting for muscle biopsy, as it provides faster, less invasive diagnosis, according to the European Society of Human Genetics 1, 3